Title |
Peritoneal Cancer Patients Not Suitable for Cytoreductive Surgery and HIPEC During Explorative Surgery: Risk Factors, Treatment Options, and Prognosis
|
---|---|
Published in |
Annals of Surgical Oncology, October 2014
|
DOI | 10.1245/s10434-014-4148-x |
Pubmed ID | |
Authors |
T. R. van Oudheusden, H. J. Braam, M. D. P. Luyer, M. J. Wiezer, B. van Ramshorst, S. W. Nienhuijs, I. H. J. T. de Hingh |
Abstract |
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is currently the only curative option for patients with peritoneal carcinomatosis of colorectal origin. Despite meticulous preoperative assessment, CRS and HIPEC appear to be impossible in a subset of patients at the time of surgery. This study investigated which clinical factors may identify these patients before surgery and reported on factors influencing survival. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ukraine | 1 | 2% |
Unknown | 57 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 14% |
Student > Ph. D. Student | 8 | 14% |
Student > Bachelor | 7 | 12% |
Student > Postgraduate | 6 | 10% |
Researcher | 4 | 7% |
Other | 9 | 16% |
Unknown | 16 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 53% |
Nursing and Health Professions | 3 | 5% |
Business, Management and Accounting | 2 | 3% |
Psychology | 2 | 3% |
Physics and Astronomy | 1 | 2% |
Other | 3 | 5% |
Unknown | 16 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2015.
All research outputs
#17,728,987
of 22,766,595 outputs
Outputs from Annals of Surgical Oncology
#4,827
of 6,447 outputs
Outputs of similar age
#172,179
of 255,780 outputs
Outputs of similar age from Annals of Surgical Oncology
#64
of 103 outputs
Altmetric has tracked 22,766,595 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,447 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,780 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.